Survivin as prognostic and predictive factor in patients treated with gemcitabine, dexamethasone, and cisplatin for relapsed or refractory aggressive NHL
Crossref DOI link: https://doi.org/10.1007/s12032-014-0244-9
Published Online: 2014-10-08
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
el Aziz, Lamiss Mohamed Abd
Text and Data Mining valid from 2014-10-08
